CLINICAL_TRIALS
trial_result
· 2014-06-26
Clinical Trial Update: NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers [Phase 1]
Summary
A Phase 1 multiple ascending dose trial of NOX-A12 in healthy volunteers has completed, in the context of hematopoietic stem cell transplantation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TME Pharma AG | Conditions: Hematopoietic Stem Cell Transplantation | Phase 1 | Status: COMPLETED